Berkshire Hathaway Inc (BRK-A)vsDrugs Made In America Acquisition II Corp. Ordinary Shares (DMII)
BRK-A
Berkshire Hathaway Inc
$712,064.33
-0.13%
FINANCIAL SERVICES · Cap: $1.02T
DMII
Drugs Made In America Acquisition II Corp. Ordinary Shares
$10.02
+0.10%
FINANCIAL SERVICES · Cap: $637.64M
Smart Verdict
WallStSmart Research — data-driven comparison
BRK-A leads profitability with a 18.0% profit margin vs 0.0%. BRK-A trades at a lower P/E of 15.3x. BRK-A earns a higher WallStSmart Score of 51/100 (C-).
BRK-A
Buy51
out of 100
Grade: C-
DMII
Avoid30
out of 100
Grade: F
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Mega-cap, among the largest globally
Reasonable price relative to book value
Strong operational efficiency at 33.0%
Conservative balance sheet, low leverage
Attractively priced relative to earnings
Generating 5.0B in free cash flow
No standout strengths identified
Areas to Watch
Weak financial health signals
Expensive relative to growth rate
Revenue declined 0.7%
Earnings declined 2.5%
0.0% revenue growth
0.0% earnings growth
Smaller company, higher risk/reward
ROE of 0.0% — below average capital efficiency
Comparative Analysis Report
WallStSmart ResearchBull Case : BRK-A
The strongest argument for BRK-A centers on Market Cap, Price/Book, Operating Margin. Profitability is solid with margins at 18.0% and operating margin at 33.0%.
Bull Case : DMII
DMII has a balanced fundamental profile.
Bear Case : BRK-A
The primary concerns for BRK-A are Piotroski F-Score, PEG Ratio, Revenue Growth.
Bear Case : DMII
The primary concerns for DMII are Revenue Growth, EPS Growth, Market Cap. A P/E of 66.7x leaves little room for execution misses.
Key Dynamics to Monitor
BRK-A profiles as a declining stock while DMII is a value play — different risk/reward profiles.
DMII is growing revenue faster at 0.0% — sustainability is the question.
BRK-A generates stronger free cash flow (5.0B), providing more financial flexibility.
Monitor INSURANCE - DIVERSIFIED industry trends, competitive dynamics, and regulatory changes.
Bottom Line
BRK-A scores higher overall (51/100 vs 30/100), backed by strong 18.0% margins. Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Berkshire Hathaway Inc
FINANCIAL SERVICES · INSURANCE - DIVERSIFIED · USA
Berkshire Hathaway Inc. is an American multinational conglomerate holding company headquartered in Omaha, Nebraska, United States. The company wholly owns GEICO, Duracell, Dairy Queen, BNSF, Lubrizol, Fruit of the Loom, Helzberg Diamonds, Long & Foster, FlightSafety International, Pampered Chef, Forest River, and NetJets, and also owns 38.6% of Pilot Flying J; and significant minority holdings in public companies Kraft Heinz Company (26.7%), American Express (18.8%), The Coca-Cola Company (9.32%), Bank of America (11.9%), and Apple (6.3%).
Visit Website →Drugs Made In America Acquisition II Corp. Ordinary Shares
FINANCIAL SERVICES · SHELL COMPANIES · USA
Drugs Made In America Acquisition II Corp. (DMII) is a special purpose acquisition company (SPAC) focused on merging with innovative firms within the pharmaceuticals and biotechnology sectors to enhance domestic drug manufacturing capabilities. Leveraging the extensive expertise of its management team, DMII identifies and executes strategic transactions that align with rising market demands and prioritize sustainable practices. Through its commitment to fostering resilient supply chains and advancing U.S. healthcare self-sufficiency, DMII aims to deliver sustained value for its shareholders and contribute to the long-term growth of the American pharmaceutical landscape.
Compare with Other INSURANCE - DIVERSIFIED Stocks
Want to dig deeper into these stocks?